Clary Sage Oil, known for its gentle, nutty aroma, is renowned as a "female essential oil" in traditional aromatherapy. It is often claimed to regulate menstruation, alleviate prenatal anxiety, and even promote uterine contractions and induce abortion. However, these claims, closely related to women's reproductive health, also make it one of the most controversial and scientifically prudent essential oils used during pregnancy.
A 2023 pilot study evaluating treatment feasibility offers fresh insights. The study recruited 11 full-term pregnant women at 38 to 40 weeks of gestation and divided them into two groups using a quasi-experimental design. Among them, 5 participants in the experimental group inhaled the scent of Clary Sage essential oil diluted 50 times, while 6 participants in the control group inhaled the same diluted odorless solvent as a placebo, with an intervention duration of 20 minutes. The study focused on analyzing the changes in the levels of two key hormones, oxytocin and cortisol, by collecting saliva samples. The study reported limited evidence of efficacy, with only three participants in the experimental group demonstrating increased oxytocin levels post-intervention. The control group showed divergent outcomes: two participants exhibited increased levels, whereas two others displayed decreased levels. Both cases involved missing data complications. Notably, no statistically significant differences were found between experimental and control groups, nor were uterine contractions observed in any participants. These findings contradict the conventional hypothesis that "clary sage oil" directly induces uterine contractions.
However, a consistent observation emerged: both groups exhibited decreased cortisol levels(a key stress biomarker post-intervention). This robust finding strongly implies that the 20-minute inhalation ritual itself, whether involving aromatic essential oils or odorless solvents, may inherently induce relaxation and mitigate stress. This highlights a methodological limitation: 27% of participants (3/11) provided insufficient saliva samples for full testing, necessitating protocol optimization in future studies. Although the pilot study did not confirm the specific effect of the low-concentration scent of Salvia miltiorrhiza on oxytocin, its good tolerance and significant stress-reducing trend laid a feasible foundation for advancing more rigorous clinical research.
Although the above research results are negative, the theoretical mechanism of action of Salvia miltiorrhiza is still worth exploring, which helps to understand the source of its traditional reputation.
1. Emotional regulation and stress relief (strongly supported by evidence):
Clary Sage is rich in linalool and linalool acetate. Phytomedicine and other studies demonstrate that these components enhance GABAergic activity, exerting sedative and anxiolytic effects. The study's cortisol reduction in both groups likely reflects HPA axis inhibition via emotional soothing - whether from essential oils or placebo scent.
2. Complexity of oxytocin release (weak and contradictory evidence):
Oxytocin is commonly referred to as the "love hormone" and plays a crucial role in childbirth, lactation, and social bonding. Its secretion is modulated by a triad of factors: emotional states, environmental cues, and psychological expectations. In theory, extreme relaxation and pleasure may promote its release. Therefore, if clary sage can effectively alleviate anxiety, it may indirectly create favorable conditions for the release of oxytocin, but this is not a direct pharmacological effect. The results of the pilot studies mentioned above indicate that even if such indirect effects exist, they may be weak and vary greatly among individuals.
Given the unclear mechanism, limited clinical evidence, and potential risks of Salvia miltiorrhiza essential oil, major aromatherapy institutions advise caution during pregnancy. The traditional warning mainly comes from the methyl salicylate component it contains, which has stimulating effects on the uterus and meridians at high concentrations. Although the risk may be reduced after extreme dilution, the related safety has never been rigorously and systematically validated. The International Federation of Professional Aromatherapists (IFPA, NAHA, etc.) generally recommends avoiding the use of clary sage essential oil during the first three months of pregnancy (early pregnancy), and only using it in extremely low doses (usually recommended concentrations below 1%) and for short-term use under the guidance of qualified healthcare professionals (such as registered aromatherapists, midwives) during mid to late pregnancy. However, there are currently no official public resources available to verify the above viewpoints.
The safety and efficacy of clary sage oil in pregnancy remain underexplored, necessitating large-scale RCTs for conclusive evidence. Until more high-quality evidence is available, prudence is not conservatism, but the most fundamental respect for maternal and infant safety. For Clary Sage product details, contact Appchem. (Email: sales@appchem.cn)